478 filings
Page 4 of 24
8-K
ATNF
180 Life Sciences Corp
7 Sep 23
Material Modifications to Rights of Security Holders
8:30am
4
ATNF
180 Life Sciences Corp
6 Sep 23
180 Life Sciences / LAWRENCE STEINMAN ownership change
6:55pm
4
ATNF
180 Life Sciences Corp
6 Sep 23
180 Life Sciences / Lawrence Marshall Gold ownership change
6:53pm
4
ATNF
180 Life Sciences Corp
6 Sep 23
180 Life Sciences / Ozan Pamir ownership change
6:30pm
4
ATNF
180 Life Sciences Corp
6 Sep 23
180 Life Sciences / Jr. Donald A. McGovern ownership change
6:28pm
4
ATNF
180 Life Sciences Corp
6 Sep 23
180 Life Sciences / Pamela G Marrone ownership change
6:24pm
S-8
ATNF
180 Life Sciences Corp
30 Aug 23
Registration of securities for employees
4:56pm
424B3
ATNF
180 Life Sciences Corp
15 Aug 23
Prospectus supplement
5:27pm
424B3
ATNF
180 Life Sciences Corp
15 Aug 23
Prospectus supplement
5:26pm
10-Q
2023 Q2
ATNF
180 Life Sciences Corp
Quarterly report
15 Aug 23
5:00pm
8-K
ATNF
180 Life Sciences Corp
15 Aug 23
180 Life Sciences Corp. Announces Pricing of $3 Million Public Offering
4:31pm
NT 10-Q
ATNF
180 Life Sciences Corp
14 Aug 23
Notice of late quarterly filing
5:00pm
424B4
ATNF
180 Life Sciences Corp
11 Aug 23
Prospectus supplement with pricing info
5:44pm
EFFECT
ATNF
180 Life Sciences Corp
10 Aug 23
Notice of effectiveness
12:15am
CORRESP
ATNF
180 Life Sciences Corp
9 Aug 23
Correspondence with SEC
12:00am
CORRESP
ATNF
180 Life Sciences Corp
9 Aug 23
Correspondence with SEC
12:00am
8-K
ATNF
180 Life Sciences Corp
7 Aug 23
180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake
9:00am
8-K
ATNF
180 Life Sciences Corp
3 Aug 23
Regulation FD Disclosure
8:00am
8-K
ATNF
180 Life Sciences Corp
31 Jul 23
180 Life Sciences Corp. Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress Appetite
8:00am
S-1/A
ATNF
180 Life Sciences Corp
IPO registration (amended)
25 Jul 23
5:02pm